iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 113.7% in February

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 70,842 shares, a growth of 113.7% from the February 12th total of 33,149 shares. Based on an average daily trading volume, of 27,581 shares, the short-interest ratio is presently 2.6 days. Approximately 1.4% of the company’s shares are short sold. Approximately 1.4% of the company’s shares are short sold. Based on an average daily trading volume, of 27,581 shares, the short-interest ratio is presently 2.6 days.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

Large investors have recently added to or reduced their stakes in the stock. Triumph Capital Management purchased a new position in iShares Genomics Immunology and Healthcare ETF during the 3rd quarter valued at about $35,000. Ameriprise Financial Inc. increased its holdings in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after buying an additional 5,540 shares during the period. Portland Global Advisors LLC lifted its holdings in iShares Genomics Immunology and Healthcare ETF by 0.7% during the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after buying an additional 684 shares during the period. Finally, Flow Traders U.S. LLC bought a new stake in iShares Genomics Immunology and Healthcare ETF during the 2nd quarter valued at $931,000.

iShares Genomics Immunology and Healthcare ETF Trading Down 2.5%

Shares of IDNA stock traded down $0.74 on Thursday, reaching $29.22. 15,533 shares of the company’s stock were exchanged, compared to its average volume of 41,275. The company’s fifty day simple moving average is $29.06 and its 200 day simple moving average is $26.34. iShares Genomics Immunology and Healthcare ETF has a 52 week low of $17.26 and a 52 week high of $31.39. The stock has a market capitalization of $146.10 million, a PE ratio of 14.76 and a beta of 1.07.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.